Related Experiment Video
Updated: Jul 4, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Roles of exosomes in immunotherapy for solid cancers
Cong Lyu1,2, Haifeng Sun3, Zhenqiang Sun4
1Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Exosomes, extracellular vesicles, show promise in solid tumor immunotherapy by influencing immune responses and serving as biomarkers. Engineered exosomes and vaccines offer potential for cancer diagnosis, treatment, and prognosis.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Immunotherapy has advanced but struggles with solid tumor efficacy.
- Exosomes are key extracellular vesicles mediating intercellular communication and biological functions.
- Exosomes possess dual roles in immunity, capable of both activation and suppression.
Purpose of the Study:
- To review exosome composition and sources within the solid cancer immune microenvironment.
- To elaborate on exosome-mediated mechanisms influencing solid cancer immunotherapy.
- To summarize clinical applications of engineered exosomes and exosome vaccines in cancer immunotherapy.
Main Methods:
- Literature review of exosome functions in the tumor microenvironment.
- Analysis of exosome-carried antigens and MHC molecules for vaccine potential.
- Exploration of exosome-based drug delivery and immunotherapy strategies.
Main Results:
- Exosomes can be leveraged as anticancer vaccines due to antigen and MHC presentation.
- Exosomes from various bodily fluids are valuable biomarkers for cancer diagnosis and prognosis.
- Exosome-based therapies demonstrate significant progress in drug delivery and immunotherapy.
Conclusions:
- Exosomes play a critical role in the solid cancer immune microenvironment, impacting immunotherapy.
- Engineered exosomes and exosome vaccines present promising clinical applications for solid cancers.
- Exosomes offer potential avenues for solid cancer diagnosis, treatment, and prognosis.
More Related Videos
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mesenchymal Stem Cells
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...